Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.
about
Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain InhibitionMedulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.Perspectives on the discovery of NOTCH2-specific inhibitors.The Notch inhibitor cowanin accelerates nicastrin degradation.Targeting Notch signalling pathway of cancer stem cells.
P2860
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Phase I trial of weekly MK-075 ...... brain tumor consortium study.
@ast
Phase I trial of weekly MK-075 ...... brain tumor consortium study.
@en
type
label
Phase I trial of weekly MK-075 ...... brain tumor consortium study.
@ast
Phase I trial of weekly MK-075 ...... brain tumor consortium study.
@en
prefLabel
Phase I trial of weekly MK-075 ...... brain tumor consortium study.
@ast
Phase I trial of weekly MK-075 ...... brain tumor consortium study.
@en
P2093
P2860
P50
P1476
Phase I trial of weekly MK-075 ...... brain tumor consortium study.
@en
P2093
Amar Gajjar
Arzu Onar-Thomas
Clinton F Stewart
Cynthia Wetmore
James M Boyett
James Olson
Larry E Kun
Lars Wagner
Lindsey M Hoffman
Richard J Gilbertson
P2860
P2888
P304
P356
10.1007/S00381-015-2725-3
P577
2015-05-01T00:00:00Z